13 drug(s) with this reaction
2,068 total reports
Therapeutic Response Unexpected has been reported as an adverse reaction across 13 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 2,068 adverse event reports mention therapeutic response unexpected in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with therapeutic response unexpected, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have therapeutic response unexpected listed in their FDA adverse event reports, sorted by report count:
In addition to therapeutic response unexpected, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
13 drug(s) manufactured by Haleon Us Holdings Llc have therapeutic response unexpected listed in their FDA adverse event reports: ACETAMINOPHEN, ASPIRIN, AND CAFFEINE, IBUPROFEN SODIUM, IBUPROFEN TABLETS, COATED, ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE, ORLISTAT, and others.
There are a combined 2,068 reports of therapeutic response unexpected across 13 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.